162515-68-6Relevant articles and documents
Preparation method of montelukast sodium side chain
-
Paragraph 0015; 0024-0033, (2020/12/30)
The invention discloses a preparation method of a montelukast sodium side chain, and high-quality montelukast sodium side chain 1- (mercaptomethyl) cyclopropylacetic acid (MLM) is obtained. Accordingto the process, 1-bromo-cyclopropylacetonitrile (MLM-5) is taken as a raw material and reacts with thioacetic acid under an alkaline condition to generate benzoic acid (1-acetonitrile cyclopropyl) methyl mercaptide (MLM-6), and an alkaline hydrolysis reaction is directly performed without treatment, so that the product 1-(mercaptomethyl) cyclopropylacetic acid (MLM) is obtained. The process is simple to operate, cheap in used materials, mild in reaction condition, low in wastewater ammonia nitrogen and easy to biochemically treat, and the product yield and purity are greatly improved.
1-mercapto methyl propyl process for the preparation of acetic acid
-
, (2019/01/28)
The invention provides a preparation method of 1-mercaptomethylcyclopropyl acetic acid. The preparation method is used for solving the problems of high cost, high toxicity, low yield and heavy environmental pollution of the existing preparation method. The preparation method comprises the step of preparing the 1-mercaptomethylcyclopropyl acetic acid with 1,4-butanediol as a starting raw material which is cheap, low in toxicity and easy to obtain as a starting raw material through reactions such as etherification or esterification, oxidization, corey-chaykovsky or simmons-smith, reduction, substitution, deprotection and the like. The preparation method provided by the invention has the technical characteristics of simple and convenient operation, easy purification of product, high yield, and suitability for industrial large production.
SYNTHESIS OF LEUKOTRIENE COMPOUNDS
-
Page/Page column 42; 26, (2008/06/13)
The present invention relates to the synthesis of leukotriene receptor agonist compounds and to novel intermediates employed in their preparation. Leukotriene agonists are used in the treatment of asthma, as well as other conditions mediated by leukotrienes such as inflammation and allergies. A compound of particular interest is montelukast and the present invention describes an improved process for making montelukast and similar compounds.